A clinical trial published in the New England Journal of Medicine showed that the oral antibiotic levofloxacin taken once-daily for six months substantially reduced the risk of developing ...

Multidrug-resistant tuberculosis (MDR-TB) poses a formidable challenge to global health, defined by resistance to at least isoniazid and rifampicin. Traditional treatment regimens are lengthy, toxic ...

Drug-resistant tuberculosis represents a major obstacle to global TB control, with outcomes that consistently fall short of WHO targets. Multidrug-resistant tuberculosis (MDR-TB) and extensively ...

More than 10 million people fall sick with tuberculosis (TB) every year. The disease remains the world’s biggest infectious disease killers with an estimated 1.25 million annual deaths. The disease is ...

A modified compound taken from bloodroot, a wildflower native to North America, effectively fights multidrug-resistant tuberculosis (TB) bacteria in the test tube, according to a new study. The ...

An international research team headed by scientists at the University of British Columbia has demonstrated how a novel semi-synthetic compound derived from sanguinarine (SG), an alkaloid extracted ...

Protocol can be used in children and pregnant women ...

They're being warned that "people may be sick for months before receiving a diagnosis, which can lengthen exposure periods" google maps Students at Southwestern College's Chula Vista campus received ...

On Thursday, San Diego County's Tuberculosis Prevention and Care Program announced a potential exposure to multidrug-resistant tuberculosis for members and visitors of Iglesia Ni Cristo in Miramar.

Despite global efforts, multidrug-resistant tuberculosis in children is rising at an alarming rate, with younger children at the highest risk of mortality—urgent action is needed to reverse the trend.

Tuberculosis (TB) is the world's biggest infectious disease killer, with multidrug-resistant TB (MDR-TB) posing a particular threat to global health. A study led by the Swiss Tropical and Public ...